🔎 Trials Near Me

Akèy › Sipwa › New Jersey

Etid klinik pou Sipwa nan New Jersey

16 etid pou Sipwa ap chèche patisipan nan sit nan New Jersey.

Vil nan New Jersey

Tèks ofisyèl etid la (Anglè)

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • IMA Clinical Research Warren, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Hackensack University Medical Center, Hackensack
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Hypertension & Nephrology Association, Eatontown
  • IMA Clinical Research Warren, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • CardioMetabolic Collaborative Clinic, Somerset
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • IMA Clinical Research Warren, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Eatontown
  • Research Site, Somerset
  • Research Site, Warren Township
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Jersey City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Clinical Research of Philadelphia, Pennington
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Premier Research, Trenton
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  • Psoriasis Treatment Center of Central New Jersey, East Windsor
  • Care Access - Hoboken, Hoboken
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Premier Research, Trenton
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Jersey City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

Metabolic Health, Bones and Nuts During Weight Loss in Adults

  • Rutgers University - NJ Inst Food Nutrition & Health, New Brunswick
Ap rekriteVolontè an sante akeyi
Laj 50 a 75 · Tout sèks · Mizajou May 13, 2026 · NCT06949280

A Study of a Weight Loss Intervention in People With Endometrial Cancer

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Fanm · Mizajou Apr 13, 2026 · NCT06751589

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

  • Frontage Clinical Services, Inc., Secaucus
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Mar 12, 2026 · NCT07465965

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.